# PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer

> **NCT01281787** · PHASE3 · COMPLETED · sponsor: **European Institute of Oncology** · enrollment: 320 (actual)

## Conditions studied

- Lung Cancer
- Atrial Fibrillation

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT01281787
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-10
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2014-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01281787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01281787, "PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01281787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*